Finally, the absence of any BRCA1 or BRCA2 mutation in majority of "high-risk" families with breast-ovarian cancer support the general hypothesis that additional breast cancer susceptibility genes remain to be identified. The gene discussed is BRCA2; the disease is Hereditary breast and ovarian cancer syndrome.